| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62135-727-90 | 62135-727 | HUMAN PRESCRIPTION DRUG | GUANFACINE HYDROCHLORIDE | guanfacine | TABLET | ORAL | 20230712 | N/A | ANDA | ANDA216399 | Chartwell RX, LLC | GUANFACINE HYDROCHLORIDE | 1 mg/1 | 90 TABLET in 1 BOTTLE (62135-727-90) |
| 62135-728-90 | 62135-728 | HUMAN PRESCRIPTION DRUG | GUANFACINE HYDROCHLORIDE | guanfacine | TABLET | ORAL | 20230712 | N/A | ANDA | ANDA216399 | Chartwell RX, LLC | GUANFACINE HYDROCHLORIDE | 2 mg/1 | 90 TABLET in 1 BOTTLE (62135-728-90) |
| 24979-198-01 | 24979-198 | HUMAN PRESCRIPTION DRUG | Guanfacine Hydrochloride | Guanfacine | TABLET | ORAL | 20220901 | N/A | ANDA | ANDA216399 | TWi Pharmaceuticals, Inc. | GUANFACINE HYDROCHLORIDE | 1 mg/1 | 100 TABLET in 1 BOTTLE (24979-198-01) |
| 24979-199-01 | 24979-199 | HUMAN PRESCRIPTION DRUG | Guanfacine Hydrochloride | Guanfacine | TABLET | ORAL | 20220901 | N/A | ANDA | ANDA216399 | TWi Pharmaceuticals, Inc. | GUANFACINE HYDROCHLORIDE | 2 mg/1 | 100 TABLET in 1 BOTTLE (24979-199-01) |